USA - NASDAQ:ZTEK - CA98942X1024 - Common Stock
The current stock price of ZTEK is 0.745 USD. In the past month the price decreased by -7.46%. In the past year, price decreased by -35.22%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 17.69 | 14.14B | ||
| SOLV | SOLVENTUM CORP | 13.39 | 13.79B | ||
| ALGN | ALIGN TECHNOLOGY INC | 13.73 | 9.63B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.82 | 5.03B | ||
| HAE | HAEMONETICS CORP/MASS | 15.65 | 3.62B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.99 | 3.64B | ||
| ICUI | ICU MEDICAL INC | 16.88 | 3.32B | ||
| XRAY | DENTSPLY SIRONA INC | 6.26 | 1.97B | ||
| UFPT | UFP TECHNOLOGIES INC | 24.32 | 1.62B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.35B | ||
| NEOG | NEOGEN CORP | 18.03 | 1.18B | ||
| EMBC | EMBECTA CORP | 4.7 | 803.07M |
Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
ZENTEK LTD
24 Corporate Ct
Guelph ONTARIO CA
Employees: 24
Phone: 18447309822
Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
The current stock price of ZTEK is 0.745 USD. The price decreased by -0.83% in the last trading session.
ZTEK does not pay a dividend.
ZTEK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
ZENTEK LTD (ZTEK) will report earnings on 2026-02-11.
The outstanding short interest for ZENTEK LTD (ZTEK) is 0.12% of its float.
ChartMill assigns a fundamental rating of 2 / 10 to ZTEK. The financial health of ZTEK is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months ZTEK reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 22.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.88% | ||
| ROE | -63.26% | ||
| Debt/Equity | 0.12 |